Clinical Trial Update: Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a conditioning regimen of melphalan and thiotepa followed by peripheral stem cell transplantation in patients with epithelial ovarian c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Melphalan (Melphalan)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED